14th Injectables Summit

The drive for at-home patient care, high-volume injectables and evolving regulations is driving the injectables landscape. Recent innovations from the FDA's groundbreaking human factor guidance for combination products to GSK's trailblazing strides in self-administered HIV medication, and MIT engineers' visionary work on implantable devices for diabetes, signal unparalleled momentum. The past 12 months have witnessed an electrifying surge in quality standards and ingenious device inventions, but challenges still persist in device design and development.

In 2024, with a renewed dedication to addressing key industry challenges, the 14th Injectables Summit stands as the premier gathering of experts, singularly committed to optimizing the journey of biopharma's injectable device development. From seamless drug-product device integration to meticulous validation and verification processes, our summit showcases state-of-the-art devices and intricate formulations, all with a steadfast focus on prioritizing patient usability.

Discuss innovations across next generation devices, high viscosity drugs, AI integration and more by sparking conversations with 80+ experts amongst Merck, Novo Nordisk, and Regeneron with 3 days of packed technical content. Whether you are in Device Design, Engineering, Integration, this is your ultimate opportunity to unite with leading minds at one of the longest standing communities this October.

Don't miss your chance to streamline your injectable combination device, with technical takeaways and practical learnings from your peers in the field.

Prices:
Conference + 2 Workshops - Drug Developer Pricing: USD 4197.00,
Conference + 1 Workshop - Drug Developer Pricing: USD 3598.00,
Conference Only - Drug Developer Pricing: USD 2999.00,
Conference + 2 Workshops - Academic Pricing: USD 3597.00,
Conference + 1 Workshop - Academic Pricing: USD 3098.00,
Conference Only - Academic Pricing: USD 2599.00,
Conference + 2 Workshops - Service Provider Pricing: USD 5097.00,
Conference + 1 Workshop - Service Provider Pricing: USD 4398.00,
Conference Only - Service Provider Pricing: USD 3699.00

Speakers: Bharat Arora Director - Global Combo Products Quality Moderna, Chanaka Amarasinghe Associate Scientific Director Bristol Myers Squibb, Cherry Wang Senior Director of Engineering Clearside Biomedical, Claus Geiger Global Device Leader and Drug Device Integrator Sanofi, Henrik Bengtsson Senior Innovation Manager Novo Nordisk, Heydy Andolz Advisor - Human Factors Engineering Eli Lilly and Company, Hiten Gutka Senior Principal Scientist, Sterile Drug Product Development Bristol Myers Squibb, Jamie Tsung Director and Head of Drug Product Formulation, Chemistry, Manufacturing and Controls Development Alnylam Pharmaceuticals, John Dinka Director - Drug Product Tech Operation Novavax, Joyce Zhao Director - Combination Product Medical Device Takeda Pharmaceutical, Leilei Zhang Associate Principal Scientist Merck and Co, Li-Chun Tsou Director, Global Drug Delivery and Aseptic Technology GSK, Lindsay Greczyn Senior Device Development Engineer Regeneron Pharmaceuticals, Michael Campbell Senior Pharmacist Johnson and Johnson, Michelle Broggi Principal Scientist Pfizer, Ning Yu Executive Director - Device and Combination Product Development Astria Therapeutics, Nirav Bhatt Associate Director - Combination Product Development and Devices Abbvie, Ramesh Kashi Formerly Senior Scientific Director Sterile Product Development Consultant, Richard Braga SRM/CDMO Lead – Devices and Combination Products Takeda Pharmaceutical, Sahab Babaee Associate Principal Scientist - Program and Device Innovation Lead Merck and Co

Others Details

Brochure: https://go.evvnt.com/2468798-3?pid=6581